These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21594892)

  • 21. JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.
    Owens CD
    J Vasc Surg; 2010 Jul; 52(1):205-7. PubMed ID: 20434300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.
    Ziakas PD
    Haematologica; 2008 Sep; 93(9):1412-4. PubMed ID: 18641024
    [No Abstract]   [Full Text] [Related]  

  • 23. Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.
    Leon A; Staropoli JF; Hernandez JM; Longtine JA; Kuo FC; Dal Cin P
    Leuk Res; 2011 Sep; 35(9):1188-92. PubMed ID: 21376394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
    Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H; Bock O
    Ann Hematol; 2007 Apr; 86(4):245-53. PubMed ID: 17262192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.
    Pardanani A; Lasho TL; Schwager S; Finke C; Hussein K; Pruthi RK; Tefferi A
    Leukemia; 2007 Aug; 21(8):1828-9. PubMed ID: 17460706
    [No Abstract]   [Full Text] [Related]  

  • 26. JAK2V617F mutation in patients with thrombosis: to screen or not to screen?
    Xavier SG; Gadelha T; Rezende SM; Zalcberg IR; Spector N
    Int J Lab Hematol; 2011 Apr; 33(2):117-24. PubMed ID: 21118380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation.
    Au WY; Fung A; Lam KY; Lie AK; Liang R; Kwong YL
    Bone Marrow Transplant; 2006 Oct; 38(8):573-4. PubMed ID: 16953212
    [No Abstract]   [Full Text] [Related]  

  • 29. A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood.
    Poodt J; Fijnheer R; Walsh IB; Hermans MH
    Hematol Oncol; 2006 Dec; 24(4):227-33. PubMed ID: 17006961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of JAK2V617F mutation and leukocytosis with thrombotic events in essential thrombocythemia.
    Hsiao HH; Yang MY; Liu YC; Lee CP; Yang WC; Liu TC; Chang CS; Lin SF
    Exp Hematol; 2007 Nov; 35(11):1704-7. PubMed ID: 17920754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses.
    McMahon C; Abu-Elmagd K; Bontempo FA; Kant JA; Swerdlow SH
    Am J Clin Pathol; 2007 May; 127(5):736-43. PubMed ID: 17439832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [JAK2 mutation and thrombosis - recommendations for screening].
    Linnemann B; Lindhoff-Last E
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2454-7. PubMed ID: 22109574
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
    Castelli R; Gallipoli P; Schiavon R; Teatini T; Deliliers GL; Bergamaschini L
    J Thromb Thrombolysis; 2019 Jan; 47(1):155-156. PubMed ID: 30478722
    [No Abstract]   [Full Text] [Related]  

  • 34. The mutant JAK2 allele burden in children with essential thrombocythemia.
    Teofili L; Cenci T; Martini M; Capodimonti S; Torti L; Giona F; Amendola A; Randi ML; Putti MC; Scapin M; Leone G; Larocca LM
    Br J Haematol; 2009 May; 145(3):430-2. PubMed ID: 19208099
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study.
    Tondeur S; Boutruche S; Biron-Andréani C; Schved JF
    Thromb Haemost; 2009 Apr; 101(4):787-9. PubMed ID: 19350131
    [No Abstract]   [Full Text] [Related]  

  • 36. Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations.
    Bousquet M; Le Guellec S; Quelen C; Rigal-Huguet F; Delsol G; Brousset P
    Hum Pathol; 2006 Nov; 37(11):1458-64. PubMed ID: 16949922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.
    Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Villamor N; Colomer D; Cervantes F
    Haematologica; 2006 Feb; 91(2):169-75. PubMed ID: 16461300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.
    Nakatani T; Imamura T; Ishida H; Wakaizumi K; Yamamoto T; Otabe O; Ishigami T; Adachi S; Morimoto A
    Pediatr Blood Cancer; 2008 Dec; 51(6):802-5. PubMed ID: 18802948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment.
    Henry L; Carillo S; Jourdan E; Arnaud A; Brun S; Lavabre-Bertrand T
    Am J Hematol; 2007 Jun; 82(6):500-1. PubMed ID: 17301972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.